We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MedImmune Licenses Inovio Cancer Vaccine

News   Aug 11, 2015

 
MedImmune Licenses Inovio Cancer Vaccine
 
 
Advertisement
 

RELATED ARTICLES

Phase 3 Clinical Trial of Belimumab for Lupus Nephritis Reports Positive Results

News

Results from the largest Phase 3 lupus nephritis clinical trial ever conducted were announced, September 16. The study, found positive results of the efficacy and safety of the drug belimumab in patients with active lupus nephritis, a condition that causes inflammation in the kidneys of patients with systemic lupus erythematosus.

READ MORE

Unique Melanoma Markers Could Pave the Way for Therapeutic Vaccines

News

Researchers have discovered new markers, known as HLA-associated peptides, that are uniquely present on melanoma tumors. This finding could pave the way for therapeutic vaccines to be developed against melanoma.

READ MORE

Biologic Therapy for Psoriasis May Also Have Applications in Heart Disease

News

Patients with psoriasis treated with biologic therapy, which are protein-based infusions to suppress inflammation, had a significant reduction in high-risk plaque in heart arteries, over one-year, according to new research.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE